Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Recent patents disclose new therapeutic agents for anxiety, depression, etc

Nov. 15, 2006

New agents for treating neurological disorders disclosed in recent patent literature

Nov. 15, 2006

Clobazam shows potential in the treatment of Lennox-Gastaut syndrome

Nov. 15, 2006

Aricept studied in pediatric brain cancer survivors

Nov. 15, 2006

Janssen selects Invega as brand name for paliperidone extended release tablets

Nov. 15, 2006

Dopamine bioactive material as a potential nerve regeneration therapy

Nov. 15, 2006

Mixed depression data for TRIDMAC

Nov. 14, 2006

Anti Aging Medical forms collaboration with AlphaRx in neuroprotection field

Nov. 14, 2006

Mirapex approved for restless legs syndrome

Nov. 13, 2006

AMPA receptor antagonist E-2007 shows positive effects as adjunct therapy to levodopa

Nov. 13, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...